Evaluation of immune cell infiltrates (so-called “immunoscoring”) has shown that the increased expression of Foxp3 in lymphocytes or in tumor cells and an increased Foxp3/CD8+ ratio are related to tumor progression (Petersen et al. 2006). The gene discussed is FOXP3; the disease is neoplasm.